Patents by Inventor NELAMANGALA NAGARAJA

NELAMANGALA NAGARAJA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF
    Publication number: 20230382988
    Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
    Type: Application
    Filed: March 6, 2023
    Publication date: November 30, 2023
    Inventors: Rachel Rebecca Barrett, Leslie S. Johnson, Sanjaya Singh, Kathleen Last-Barney, Daw-Tsun Shih, Patricia Giblin, Scott Brodeur, Nelamangala Nagaraja
  • Compound targeting IL-23A and TNF-alpha and uses thereof
    Patent number: 11680096
    Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: June 20, 2023
    Assignees: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, MACROGENICS, INC.
    Inventors: Rachel Rebecca Barrett, Leslie S. Johnson, Sanjaya Singh, Kathleen Last-Barney, Daw-Tsun Shih, Patricia Giblin, Scott Brodeur, Nelamangala Nagaraja
  • METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY
    Publication number: 20220362250
    Abstract: Provided are methods of treating a brain tumor in a patient in need thereof comprising administering to the patient a compound described herein and radiation therapy and/or one or more additional therapeutic agents.
    Type: Application
    Filed: June 12, 2018
    Publication date: November 17, 2022
    Inventors: Joshua MURTIE, Nelamangala NAGARAJA, Brandon NICOLAY, David SCHENKEIN, Katharine YEN
  • Methods of treating brain tumors using combination therapy
    Patent number: 11458127
    Abstract: Provided are methods of treating a brain tumor in a patient in need thereof comprising administering to the patient a compound described herein and radiation therapy and/or one or more additional therapeutic agents.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: October 4, 2022
    Assignee: AGIOS PHARMACEUTICALS, INC.
    Inventors: Joshua Murtie, Nelamangala Nagaraja, Brandon Nicolay, David Schenkein, Katharine Yen
  • COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF
    Publication number: 20210054065
    Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
    Type: Application
    Filed: August 26, 2020
    Publication date: February 25, 2021
    Inventors: Rachel Rebecca Barrett, Leslie S. Johnson, Sanjaya Singh, Kathleen Last-Barney, Daw-Tsun Shih, Patricia Giblin, Scott Brodeur, Nelamangala Nagaraja
  • METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY
    Publication number: 20210046081
    Abstract: Provided are methods of treating a brain tumor in a patient in need thereof comprising administering to the patient a compound described herein and radiation therapy and/or one or more additional therapeutic agents.
    Type: Application
    Filed: August 25, 2020
    Publication date: February 18, 2021
    Inventors: Joshua Murtie, Nelamangala Nagaraja, Brandon Nicolay, David Schenkein, Katharine Yen
  • Compound targeting IL-23A and TNF-alpha and uses thereof
    Patent number: 10793629
    Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: October 6, 2020
    Assignees: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, MACROGENICS, INC.
    Inventors: Rachel Rebecca Barrett, Leslie S. Johnson, Sanjaya Singh, Kathleen Last-Barney, Daw-Tsun Shih, Patricia Giblin, Scott Brodeur, Nelamangala Nagaraja
  • Methods of treating brain tumors using combination therapy
    Patent number: 10780093
    Abstract: Provided are methods of treating a brain tumor in a patient in need thereof comprising administering to the patient a compound described herein and radiation therapy and/or one or more additional therapeutic agents.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: September 22, 2020
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Joshua Murtie, Nelamangala Nagaraja, Brandon Nicolay, David Schenkein, Katharine Yen
  • METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY
    Publication number: 20200129491
    Abstract: Provided are methods of treating a brain tumor in a patient in need thereof comprising administering to the patient a compound described herein and radiation therapy and/or one or more additional therapeutic agents.
    Type: Application
    Filed: June 12, 2018
    Publication date: April 30, 2020
    Inventors: Joshua MURTIE, Nelamangala NAGARAJA, Brandon NICOLAY, David SCHENKEIN, Katharine YEN
  • COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF
    Publication number: 20190016794
    Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
    Type: Application
    Filed: August 1, 2018
    Publication date: January 17, 2019
    Inventors: Rachel Rebecca Barrett, Leslie S. Johnson, Sanjaya Singh, Kathleen Last-Barney, Daw-Tsun Shih, Patricia Giblin, Scott Brodeur, Nelamangala Nagaraja
  • METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY
    Publication number: 20180353514
    Abstract: Provided are methods of treating a brain tumor in a patient in need thereof comprising administering to the patient a compound described herein and radiation therapy and/or one or more additional therapeutic agents.
    Type: Application
    Filed: June 12, 2018
    Publication date: December 13, 2018
    Applicant: AGIOS PHARMACEUTICALS, INC.
    Inventors: Joshua MURTIE, Nelamangala NAGARAJA, Brandon NICOLAY, David Schenkein, Katharine YEN
  • METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY
    Publication number: 20180353491
    Abstract: Provided are methods of treating a brain tumor in a patient in need thereof comprising administering to the patient a compound described herein and radiation therapy and/or one or more additional therapeutic agents.
    Type: Application
    Filed: June 12, 2018
    Publication date: December 13, 2018
    Applicant: AGIOS PHARMACEUTICALS, INC.
    Inventors: Joshua MURTIE, Nelamangala NAGARAJA, Brandon NICOLAY, David Schenkein, Katharine YEN
  • Compound targeting IL-23A and TNF-alpha and uses thereof
    Patent number: 10059763
    Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: August 28, 2018
    Assignees: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, MACROGENICS, INC.
    Inventors: Rachel Rebecca Barrett, Leslie S. Johnson, Sanjaya Singh, Kathleen Last-Barney, Daw-Tsun Shih, Patricia Giblin, Scott Brodeur, Nelamangala Nagaraja
  • COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF
    Publication number: 20160060338
    Abstract: The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
    Type: Application
    Filed: September 3, 2015
    Publication date: March 3, 2016
    Inventors: RACHEL REBECCA BARRETT, LESLIE S. JOHNSON, SANJAYA SINGH, KATHLEEN LAST-BARNEY, DAW-TSUN SHIH, PATRICIA GIBLIN, SCOTT BRODEUR, NELAMANGALA NAGARAJA